nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—HSF1 activation—VCP—Paget's disease of bone	0.0684	0.219	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular response to heat stress—VCP—Paget's disease of bone	0.0272	0.087	CbGpPWpGaD
Nedocromil—Ocular hyperaemia—Zoledronate—Paget's disease of bone	0.0235	0.0342	CcSEcCtD
Nedocromil—Rhinitis—Tiludronate—Paget's disease of bone	0.0195	0.0284	CcSEcCtD
Nedocromil—Otitis media—Risedronate—Paget's disease of bone	0.0163	0.0237	CcSEcCtD
Nedocromil—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—OPTN—Paget's disease of bone	0.0163	0.0521	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.0156	0.0499	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.0155	0.0495	CbGpPWpGaD
Nedocromil—PTGDR—G alpha (s) signalling events—CALCA—Paget's disease of bone	0.0154	0.0491	CbGpPWpGaD
Nedocromil—Arthritis—Etidronic acid—Paget's disease of bone	0.0139	0.0202	CcSEcCtD
Nedocromil—Cough increased—Risedronate—Paget's disease of bone	0.0139	0.0202	CcSEcCtD
Nedocromil—HSP90AA1—G2/M Transition—OPTN—Paget's disease of bone	0.0122	0.0391	CbGpPWpGaD
Nedocromil—Dyspepsia—Tiludronate—Paget's disease of bone	0.0122	0.0177	CcSEcCtD
Nedocromil—HSP90AA1—Mitotic G2-G2/M phases—OPTN—Paget's disease of bone	0.0121	0.0386	CbGpPWpGaD
Nedocromil—Pain—Tiludronate—Paget's disease of bone	0.0118	0.0172	CcSEcCtD
Nedocromil—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.0113	0.0165	CcSEcCtD
Nedocromil—Abdominal pain—Tiludronate—Paget's disease of bone	0.0109	0.0159	CcSEcCtD
Nedocromil—Gastroenteritis—Risedronate—Paget's disease of bone	0.0104	0.0151	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.01	0.032	CbGpPWpGaD
Nedocromil—Asthenia—Tiludronate—Paget's disease of bone	0.00992	0.0144	CcSEcCtD
Nedocromil—Arthritis—Risedronate—Paget's disease of bone	0.00948	0.0138	CcSEcCtD
Nedocromil—Diarrhoea—Tiludronate—Paget's disease of bone	0.00946	0.0138	CcSEcCtD
Nedocromil—Dizziness—Tiludronate—Paget's disease of bone	0.00914	0.0133	CcSEcCtD
Nedocromil—Headache—Tiludronate—Paget's disease of bone	0.00866	0.0126	CcSEcCtD
Nedocromil—Arthritis—Zoledronate—Paget's disease of bone	0.00823	0.012	CcSEcCtD
Nedocromil—Nausea—Tiludronate—Paget's disease of bone	0.00821	0.012	CcSEcCtD
Nedocromil—Influenza—Risedronate—Paget's disease of bone	0.00796	0.0116	CcSEcCtD
Nedocromil—HSP90AA1—Influenza Viral RNA Transcription and Replication—NUP205—Paget's disease of bone	0.00792	0.0253	CbGpPWpGaD
Nedocromil—Bronchitis—Risedronate—Paget's disease of bone	0.00766	0.0111	CcSEcCtD
Nedocromil—Influenza—Pamidronate—Paget's disease of bone	0.00757	0.011	CcSEcCtD
Nedocromil—HSP90AA1—Influenza Life Cycle—NUP205—Paget's disease of bone	0.0075	0.024	CbGpPWpGaD
Nedocromil—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.0074	0.0108	CcSEcCtD
Nedocromil—HSP90AA1—Influenza Infection—NUP205—Paget's disease of bone	0.00729	0.0233	CbGpPWpGaD
Nedocromil—Leukopenia—Etidronic acid—Paget's disease of bone	0.00726	0.0106	CcSEcCtD
Nedocromil—Pneumonia—Risedronate—Paget's disease of bone	0.00714	0.0104	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00704	0.0102	CcSEcCtD
Nedocromil—Influenza—Zoledronate—Paget's disease of bone	0.00691	0.0101	CcSEcCtD
Nedocromil—Conjunctivitis—Risedronate—Paget's disease of bone	0.0069	0.01	CcSEcCtD
Nedocromil—Pneumonia—Pamidronate—Paget's disease of bone	0.00679	0.00988	CcSEcCtD
Nedocromil—Dysgeusia—Alendronate—Paget's disease of bone	0.00677	0.00986	CcSEcCtD
Nedocromil—Sinusitis—Risedronate—Paget's disease of bone	0.00666	0.00969	CcSEcCtD
Nedocromil—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00656	0.00955	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00643	0.00935	CcSEcCtD
Nedocromil—Rhinitis—Risedronate—Paget's disease of bone	0.00639	0.0093	CcSEcCtD
Nedocromil—Sinusitis—Pamidronate—Paget's disease of bone	0.00633	0.00922	CcSEcCtD
Nedocromil—Pharyngitis—Risedronate—Paget's disease of bone	0.00633	0.00921	CcSEcCtD
Nedocromil—Rhinitis—Pamidronate—Paget's disease of bone	0.00607	0.00884	CcSEcCtD
Nedocromil—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00599	0.00872	CcSEcCtD
Nedocromil—Chest pain—Alendronate—Paget's disease of bone	0.00589	0.00857	CcSEcCtD
Nedocromil—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00583	0.00848	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—VCP—Paget's disease of bone	0.00577	0.0184	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CALCA—Paget's disease of bone	0.00577	0.0184	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CALCA—Paget's disease of bone	0.00557	0.0178	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00542	0.0173	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00542	0.00788	CcSEcCtD
Nedocromil—Urticaria—Etidronic acid—Paget's disease of bone	0.00526	0.00766	CcSEcCtD
Nedocromil—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00524	0.00762	CcSEcCtD
Nedocromil—Dysgeusia—Pamidronate—Paget's disease of bone	0.00516	0.00752	CcSEcCtD
Nedocromil—Dyspepsia—Alendronate—Paget's disease of bone	0.00497	0.00723	CcSEcCtD
Nedocromil—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00488	0.0071	CcSEcCtD
Nedocromil—Cough—Risedronate—Paget's disease of bone	0.00484	0.00705	CcSEcCtD
Nedocromil—Pain—Alendronate—Paget's disease of bone	0.00483	0.00702	CcSEcCtD
Nedocromil—Chest pain—Risedronate—Paget's disease of bone	0.00472	0.00687	CcSEcCtD
Nedocromil—Leukopenia—Pamidronate—Paget's disease of bone	0.00472	0.00687	CcSEcCtD
Nedocromil—Dysgeusia—Zoledronate—Paget's disease of bone	0.00472	0.00687	CcSEcCtD
Nedocromil—Dry mouth—Risedronate—Paget's disease of bone	0.00462	0.00672	CcSEcCtD
Nedocromil—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00461	0.00672	CcSEcCtD
Nedocromil—Cough—Pamidronate—Paget's disease of bone	0.0046	0.0067	CcSEcCtD
Nedocromil—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00453	0.0066	CcSEcCtD
Nedocromil—Tremor—Zoledronate—Paget's disease of bone	0.00451	0.00657	CcSEcCtD
Nedocromil—Urticaria—Alendronate—Paget's disease of bone	0.00448	0.00652	CcSEcCtD
Nedocromil—Abdominal pain—Alendronate—Paget's disease of bone	0.00446	0.00649	CcSEcCtD
Nedocromil—Body temperature increased—Alendronate—Paget's disease of bone	0.00446	0.00649	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—CALCA—Paget's disease of bone	0.00437	0.014	CbGpPWpGaD
Nedocromil—Leukopenia—Zoledronate—Paget's disease of bone	0.00431	0.00628	CcSEcCtD
Nedocromil—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.0043	0.00626	CcSEcCtD
Nedocromil—Vomiting—Etidronic acid—Paget's disease of bone	0.00421	0.00613	CcSEcCtD
Nedocromil—Cough—Zoledronate—Paget's disease of bone	0.0042	0.00612	CcSEcCtD
Nedocromil—Rash—Etidronic acid—Paget's disease of bone	0.00418	0.00608	CcSEcCtD
Nedocromil—Dermatitis—Etidronic acid—Paget's disease of bone	0.00417	0.00607	CcSEcCtD
Nedocromil—Hypersensitivity—Alendronate—Paget's disease of bone	0.00416	0.00605	CcSEcCtD
Nedocromil—Headache—Etidronic acid—Paget's disease of bone	0.00415	0.00604	CcSEcCtD
Nedocromil—Chest pain—Zoledronate—Paget's disease of bone	0.0041	0.00597	CcSEcCtD
Nedocromil—Asthenia—Alendronate—Paget's disease of bone	0.00405	0.00589	CcSEcCtD
Nedocromil—Dyspnoea—Risedronate—Paget's disease of bone	0.00404	0.00588	CcSEcCtD
Nedocromil—Dry mouth—Zoledronate—Paget's disease of bone	0.00401	0.00584	CcSEcCtD
Nedocromil—Dyspepsia—Risedronate—Paget's disease of bone	0.00399	0.0058	CcSEcCtD
Nedocromil—Nausea—Etidronic acid—Paget's disease of bone	0.00393	0.00573	CcSEcCtD
Nedocromil—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00393	0.00572	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00391	0.00569	CcSEcCtD
Nedocromil—Fatigue—Risedronate—Paget's disease of bone	0.0039	0.00568	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00389	0.0124	CbGpPWpGaD
Nedocromil—Pain—Risedronate—Paget's disease of bone	0.00387	0.00564	CcSEcCtD
Nedocromil—Diarrhoea—Alendronate—Paget's disease of bone	0.00386	0.00562	CcSEcCtD
Nedocromil—Dyspnoea—Pamidronate—Paget's disease of bone	0.00384	0.00559	CcSEcCtD
Nedocromil—Dyspepsia—Pamidronate—Paget's disease of bone	0.00379	0.00551	CcSEcCtD
Nedocromil—Dizziness—Alendronate—Paget's disease of bone	0.00373	0.00543	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00372	0.00541	CcSEcCtD
Nedocromil—Fatigue—Pamidronate—Paget's disease of bone	0.00371	0.0054	CcSEcCtD
Nedocromil—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.0037	0.00539	CcSEcCtD
Nedocromil—Pain—Pamidronate—Paget's disease of bone	0.00368	0.00536	CcSEcCtD
Nedocromil—Urticaria—Risedronate—Paget's disease of bone	0.0036	0.00524	CcSEcCtD
Nedocromil—Vomiting—Alendronate—Paget's disease of bone	0.00359	0.00522	CcSEcCtD
Nedocromil—Body temperature increased—Risedronate—Paget's disease of bone	0.00358	0.00521	CcSEcCtD
Nedocromil—Abdominal pain—Risedronate—Paget's disease of bone	0.00358	0.00521	CcSEcCtD
Nedocromil—Rash—Alendronate—Paget's disease of bone	0.00356	0.00518	CcSEcCtD
Nedocromil—Dermatitis—Alendronate—Paget's disease of bone	0.00355	0.00517	CcSEcCtD
Nedocromil—Headache—Alendronate—Paget's disease of bone	0.00354	0.00515	CcSEcCtD
Nedocromil—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00352	0.00512	CcSEcCtD
Nedocromil—Dyspnoea—Zoledronate—Paget's disease of bone	0.00351	0.0051	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—OPTN—Paget's disease of bone	0.00348	0.0111	CbGpPWpGaD
Nedocromil—Dyspepsia—Zoledronate—Paget's disease of bone	0.00346	0.00504	CcSEcCtD
Nedocromil—Abdominal pain—Pamidronate—Paget's disease of bone	0.0034	0.00495	CcSEcCtD
Nedocromil—Body temperature increased—Pamidronate—Paget's disease of bone	0.0034	0.00495	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00339	0.00494	CcSEcCtD
Nedocromil—Fatigue—Zoledronate—Paget's disease of bone	0.00339	0.00493	CcSEcCtD
Nedocromil—Pain—Zoledronate—Paget's disease of bone	0.00336	0.00489	CcSEcCtD
Nedocromil—Nausea—Alendronate—Paget's disease of bone	0.00335	0.00488	CcSEcCtD
Nedocromil—Hypersensitivity—Risedronate—Paget's disease of bone	0.00334	0.00486	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00326	0.0104	CbGpPWpGaD
Nedocromil—Asthenia—Risedronate—Paget's disease of bone	0.00325	0.00473	CcSEcCtD
Nedocromil—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00322	0.00468	CcSEcCtD
Nedocromil—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00317	0.00462	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00315	0.0101	CbGpPWpGaD
Nedocromil—Urticaria—Zoledronate—Paget's disease of bone	0.00312	0.00455	CcSEcCtD
Nedocromil—Abdominal pain—Zoledronate—Paget's disease of bone	0.00311	0.00452	CcSEcCtD
Nedocromil—Body temperature increased—Zoledronate—Paget's disease of bone	0.00311	0.00452	CcSEcCtD
Nedocromil—Diarrhoea—Risedronate—Paget's disease of bone	0.0031	0.00451	CcSEcCtD
Nedocromil—Asthenia—Pamidronate—Paget's disease of bone	0.00309	0.00449	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—VCP—Paget's disease of bone	0.00308	0.00986	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CALCA—Paget's disease of bone	0.00303	0.00969	CbGpPWpGaD
Nedocromil—Dizziness—Risedronate—Paget's disease of bone	0.00299	0.00436	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—VCP—Paget's disease of bone	0.00298	0.00952	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CALCA—Paget's disease of bone	0.00296	0.00946	CbGpPWpGaD
Nedocromil—Diarrhoea—Pamidronate—Paget's disease of bone	0.00295	0.00429	CcSEcCtD
Nedocromil—Hypersensitivity—Zoledronate—Paget's disease of bone	0.0029	0.00422	CcSEcCtD
Nedocromil—Vomiting—Risedronate—Paget's disease of bone	0.00288	0.00419	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CALCA—Paget's disease of bone	0.00286	0.00914	CbGpPWpGaD
Nedocromil—Rash—Risedronate—Paget's disease of bone	0.00286	0.00416	CcSEcCtD
Nedocromil—Dermatitis—Risedronate—Paget's disease of bone	0.00285	0.00415	CcSEcCtD
Nedocromil—Dizziness—Pamidronate—Paget's disease of bone	0.00285	0.00414	CcSEcCtD
Nedocromil—Headache—Risedronate—Paget's disease of bone	0.00284	0.00413	CcSEcCtD
Nedocromil—Asthenia—Zoledronate—Paget's disease of bone	0.00282	0.00411	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.00277	0.00884	CbGpPWpGaD
Nedocromil—Vomiting—Pamidronate—Paget's disease of bone	0.00274	0.00398	CcSEcCtD
Nedocromil—Rash—Pamidronate—Paget's disease of bone	0.00271	0.00395	CcSEcCtD
Nedocromil—Dermatitis—Pamidronate—Paget's disease of bone	0.00271	0.00395	CcSEcCtD
Nedocromil—Headache—Pamidronate—Paget's disease of bone	0.0027	0.00392	CcSEcCtD
Nedocromil—Diarrhoea—Zoledronate—Paget's disease of bone	0.00269	0.00392	CcSEcCtD
Nedocromil—Nausea—Risedronate—Paget's disease of bone	0.00269	0.00391	CcSEcCtD
Nedocromil—Dizziness—Zoledronate—Paget's disease of bone	0.0026	0.00378	CcSEcCtD
Nedocromil—Nausea—Pamidronate—Paget's disease of bone	0.00256	0.00372	CcSEcCtD
Nedocromil—Vomiting—Zoledronate—Paget's disease of bone	0.0025	0.00364	CcSEcCtD
Nedocromil—Rash—Zoledronate—Paget's disease of bone	0.00248	0.00361	CcSEcCtD
Nedocromil—Dermatitis—Zoledronate—Paget's disease of bone	0.00248	0.0036	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—NUP205—Paget's disease of bone	0.00247	0.00791	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00247	0.0079	CbGpPWpGaD
Nedocromil—Headache—Zoledronate—Paget's disease of bone	0.00246	0.00358	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—VCP—Paget's disease of bone	0.00234	0.00747	CbGpPWpGaD
Nedocromil—Nausea—Zoledronate—Paget's disease of bone	0.00234	0.0034	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CALCA—Paget's disease of bone	0.00224	0.00717	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.0018	0.00576	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CALCA—Paget's disease of bone	0.00175	0.00559	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00174	0.00556	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00171	0.00548	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CALCA—Paget's disease of bone	0.00169	0.0054	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—VCP—Paget's disease of bone	0.00166	0.00531	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VCP—Paget's disease of bone	0.00162	0.00518	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CALCA—Paget's disease of bone	0.00156	0.00497	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NUP205—Paget's disease of bone	0.00137	0.00439	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00137	0.00436	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CALCA—Paget's disease of bone	0.00133	0.00424	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NUP205—Paget's disease of bone	0.00127	0.00406	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PML—Paget's disease of bone	0.00121	0.00388	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—INPP5D—Paget's disease of bone	0.00117	0.00375	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VCP—Paget's disease of bone	0.00116	0.00372	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NUP205—Paget's disease of bone	0.00106	0.0034	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SQSTM1—Paget's disease of bone	0.00105	0.00336	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000946	0.00302	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CALCA—Paget's disease of bone	0.000942	0.00301	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CALCA—Paget's disease of bone	0.000919	0.00294	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—INPP5D—Paget's disease of bone	0.000906	0.0029	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000679	0.00217	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CALCA—Paget's disease of bone	0.00066	0.00211	CbGpPWpGaD
